Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancers, UTIs (urinary tract infections) and AF (atrial fibrillation) feature in hefty new NICE (UK National Institute for Clinical Excellence) agenda

This article was originally published in Clinica

Executive Summary

Thrombophilia screening and the diagnosis and management of cancers, urinary tract infections (UTIs) and atrial fibrillation (AF) are among the ten technologies and seven areas of clinical practice that the UK's National Institute for Clinical Excellence (NICE) has been commissioned by the Department of Health to undertake under its ninth work programme.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063927

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel